TareBio
New accelerator entry · 2026-07-31 · the record
In their words
Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.
What the record says
Founder & CEO, TareBio (YC S26). MD-PhD from UCLA-Caltech, where she built a novel platform that develops vaccines for any cancer or infection in weeks, funded by the Gates Foundation. BS in Biology from MIT. Conducted research at the Koch Institute, Harvard Medical School, and the Weizmann. Select Awards: UCLA MD-PhD Merit Scholar, UCLA TDG Senior Fellow, MIT iGEM Gold Medal, MIT IDEAs winner, MIT Dean Advisory Group, WhiteHouse Science Fair, Bessie Lawrence Scholar, Intel STS Finalist
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
Against the 209 companies on file from Summer 2026. Median team 2, largest 30.
The nearest companies on file from the same batch, side by side with this one.
| Company | Batch | Sectors | Listed |
|---|---|---|---|
| Frontier Computing | Summer 2026 | Artificial Intelligence, Hard Tech, Hardware | 2026-08-31 |
| Ethos Space Resources | Summer 2026 | Hard Tech, Exascale Computing, Energy | 2026-08-23 |
| Spectre Intelligence | Summer 2026 | Biotech, Investing, Trading | 2026-08-22 |
| Edgerun | Summer 2026 | Robotics, Defense | 2026-08-21 |
| Allia Health | Summer 2026 | Artificial Intelligence, Healthcare, Mental Health | 2026-08-19 |
| TareBio (this page) | Summer 2026 | Vaccines, Synthetic Biology, Biotechnology | 2026-07-31 |
Click a column heading to sort. Comparison is against records held here, not against every company that exists.
The full profile
The rest of this profile is open on any paid or trial plan
It costs no credits. It is a plan check and nothing else.
- Source Check — verify Eta Atolia's other claims against the registers that hold them.
- INVEST — compare this company against the peers above, on the numbers.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Eta Atolia for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist TareBioYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind TareBio: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry. Figures are read directly from the source record; names have not been matched against other people.